Basma Adeem Medical company (TADAWUL:9626)
Saudi Arabia flag Saudi Arabia · Delayed Price · Currency is SAR
4.800
0.00 (0.00%)
Jul 24, 2025, 3:18 PM AST

TADAWUL:9626 Income Statement

Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
33.9226.5221.92
Revenue Growth (YoY)
27.88%20.99%-
Cost of Revenue
22.9818.1915.02
Gross Profit
10.948.336.9
Selling, General & Admin
3.142.482.57
Operating Expenses
3.412.742.69
Operating Income
7.525.594.21
Interest Expense
-0.34-0.36-0.29
Interest & Investment Income
0.1--
Other Non Operating Income (Expenses)
-0.5-0.3-
EBT Excluding Unusual Items
6.784.933.92
Other Unusual Items
-00.13-
Pretax Income
6.785.063.92
Income Tax Expense
0.480.190.14
Net Income
6.34.873.78
Net Income to Common
6.34.873.78
Net Income Growth
29.40%28.71%-
Shares Outstanding (Basic)
1210-
Shares Outstanding (Diluted)
1210-
Shares Change (YoY)
21.59%--
EPS (Basic)
0.550.51-
EPS (Diluted)
0.550.51-
EPS Growth
6.42%--
Free Cash Flow
6.664.075.24
Free Cash Flow Per Share
0.580.43-
Gross Margin
32.25%31.41%31.46%
Operating Margin
22.18%21.07%19.20%
Profit Margin
18.58%18.36%17.26%
Free Cash Flow Margin
19.64%15.34%23.90%
EBITDA
8.156.24.54
EBITDA Margin
24.02%23.36%20.71%
D&A For EBITDA
0.620.610.33
EBIT
7.525.594.21
EBIT Margin
22.18%21.07%19.20%
Effective Tax Rate
7.11%3.69%3.56%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.